IL-6 levels decrease with SSRI treatment in patients with major depression

2005222 citationsJournal Article

Authors

Ayşe Devrim Başterzi · Mersin Üniversitesi

Çiğdem Aydemir · Ankara Numune Eğitim ve Araştırma Hastanesi

Cebrail Kısa · Ankara Numune Eğitim ve Araştırma Hastanesi

Sebahat Aksaray · Ankara Numune Eğitim ve Araştırma Hastanesi

Verda Tüzer · Ankara Numune Eğitim ve Araştırma Hastanesi

Kemal Yazıcı · Mersin Üniversitesi

Erol Göka

Abstract

The results of this study suggest that proinflammatory cytokines show some changes during the course of treatment of major depression. These findings might also be considered as supporting the hypothesis of a modulatory role of antidepressants on the immune system.

Topics & Keywords

Stress Responses and Cortisol Tryptophan and brain disorders Treatment of Major Depression

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Human Psychopharmacology Clinical and Experimental

Volume 20, Issue 7, pp. 473-476

DOI: 10.1002/hup.717

Field-Weighted Citation Impact: 1.73